biotools vanguard logo

BioTools Innovator VANGUARD  Accelerator

BioTools Innovator VANGUARD wraparound Accelerator program as part of the core BioTools Innovator annual cohort will select up to 10 companies annually to participate in the four-month program.

Applying to BioTools Innovator VANGUARD

All early-stage innovators developing tools and services for biotechnology, biomedicine, cell biology, molecular biology, genetics, and biochemistry with uses for public health emergencies are encouraged to apply.

Apply Now

Preferably, applicants will have prototype or proof of concept evidence and available financial runway remaining to execute on current milestones. Founders who have developed an applicable technology but have yet to form a company may still apply; however, they must be incorporated as a company before starting the accelerator program.

Companies accepted to the program must commit a (co-)founder, chief executive officer, or appropriate senior member of their leadership team to participate in the four-month virtual accelerator program and be present for the Capstone Event showcase and finals in October.

The BioTools Innovator VANGUARD Experience for Life Science Tools Startups

mentorship

Mentorship

In-depth, customized mentorship from senior industry leaders featuring pitch coaching, goal setting, value proposition development, and corporate mentorship.

curriculum

Educational Curriculum

A bespoke educational curriculum, including cohort-driven webinars, open office hours, and hands-on workshops.

community

Community

Engagement with a robust ecosystem of peers, alumni, and strategic subject matter experts.

recognition

Recognition & Visibility

Recognition and visibility to potential partners, investors, and suppliers.

resources and funding

Resources & Funding

Access to unparalleled resource opportunities through networking, leading industry events, and BTI's ecosystem.

Backed by BioTools Innovator, the First Accelerator Focused on Life Science Tools

Since 2012, MedTech Innovator (“MTI”) has built a proven track record of identifying and transitioning research and development products of all stages of technology readiness to follow-on investment and successful commercialization. MedTech Innovator has been a catalyst for groundbreaking healthcare solutions, reviewing 12,000 applicants and fostering the growth of 612 companies that have collectively raised over $8 billion in follow-on funding and introduced more than 350 products to the market, transforming the lives of millions. 

In 2021, MTI launched BioTools Innovator, the first-ever accelerator dedicated to life science tools and diagnostics, which leverages MTI’s successful accelerator model to advance innovation in areas such as drug and vaccine discovery and development, diagnostics development, and biomanufacturing.

Who Should Apply?

research

Research Products & Instruments

Companies that manufacture and/or sell kits, assays, reagents and instruments that are used in corporate R&D, drug discovery, manufacturing and academic research. Products are not subject to regulatory approval.

manufacturing

R&D & Manufacturing Services

Companies that provide outsourced services to academic labs and companies in biophrama, diagnostics, agriculture and food at all stages of R&D.

drug discovery

Drug Discovery Technologies

Companies utilizing technologies enabling the discovery, development, manufacturing and delivery of drugs.

Common Use Cases for Technologies Suitable for BioTools Innovator:

  • Cell Research, Analysis, and Imaging
  • Drug Discovery, Lead Selection, Drug Formulation, and Preclinical Development
  • Bioproduction
  • Protein Analysis
  • Clinical Development
  • Sequencing
  • Nucleic Acid Reagents and Instruments
  • Automation
  • Informatics & Data
  • Cell Engineering Technologies
  • Cell and Gene Therapy
  • Microbiome Analysis
  • Synthetic Biology
  • Diagnostic and Biomarker Discovery
  • Other Molecular Biology